Clinical Trial Update: Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the Vi polysaccharide vaccine against Typhoid fever (and Paratyphoid fever) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paratyphoid Fever
• Typhoid Fever

Drugs mentioned

• Vi polysaccharide vaccine (Vi polysaccharide vaccine)

Snippet

Sponsor: International Vaccine Institute | Conditions: Typhoid, Paratyphoid Fever | Phase 4 | Status: COMPLETED